Privi Speciality Chemicals Limited — Important, 12-02-2025: Updates
The Board of Directors of Privi Speciality Chemicals Limited has convened a meeting where they approved the unaudited financial results for the quarter and nine months ended December 31, 2024. Total income for the quarter amounted to ₹49,924.49 crore, with a net profit of ₹30,351.65 crore. For the nine months, total income reached ₹1,45,767.47 crore, resulting in a net profit of ₹83,783.34 crore. The statutory auditors issued an unmodified review conclusion.
Additionally, Mr. Dwarko Topandas Khilnani has tendered his resignation as a Non-Executive Independent Director, effective March 31, 2025, due to health concerns. His contributions were acknowledged during the board meeting. The composition of various board committees has also been restructured, reflecting a commitment to governance and strategic oversight.
The company maintains a positive outlook, reinforced by strong financial performance and governance structures. Investors should monitor further developments closely, particularly the effects of leadership changes and strategic initiatives on operational efficiency and growth potential.
